Similar articles

• Bisphosphonate-related osteonecrosis of the jaw: background and guidelines for diagnosis, staging and management.

  Ruggiero SL, Fantasia J, Carlson E. Ruggiero SL, et al. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006 Oct;102(4):433-41. doi: 10.1016/j.tripleo.2006.06.004. Epub 2006 Jul 31. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 2006. PMID: 16997108 No abstract available.
• [Bisphosphonates (BP) and osteonecrosis of the jaws; continuous treatment with Bisphosphonates should be considered].

  Mawatari T. Mawatari T. Clin Calcium. 2010 Nov;20(11):1743-7. Clin Calcium. 2010. PMID: 21066910 Review. Japanese. No abstract available.
• Management of patients on bisphosphonates and prevention of bisphosphonate-related osteonecrosis of the jaw.

  Chu V; American Association of Oral and Maxillofacial Surgeons; American Dental Association. Chu V, et al. Hawaii Dent J. 2008 Sep-Oct;39(5):9-12; quiz 17. Hawaii Dent J. 2008. PMID: 19189512
• Osteonecrosis in the jaws of patients who are using oral biphosphonates to treat osteoporosis.

  Dello Russo NM, Jeffcoat MK, Marx RE, Fugazzotto P. Dello Russo NM, et al. Int J Oral Maxillofac Implants. 2007 Jan-Feb;22(1):146-53. Int J Oral Maxillofac Implants. 2007. PMID: 17340909 No abstract available.
• Intravenous bisphosphonate therapy and bisphosphonate-related osteonecrosis of the jaws.

  Dodson TB. Dodson TB. J Oral Maxillofac Surg. 2009 May;67(5 Suppl):44-52. doi: 10.1016/j.joms.2008.12.004. J Oral Maxillofac Surg. 2009. PMID: 19371814 Review.